2BB score and signals
Werewolf Therapeutics, Inc.’s current 2BB score is 12 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 28 | Weak |
| Quality | 60 | Strong |
| Risk | 65 | High |
Company facts
| Headquarters | Watertown, Massachusetts, United States |
| Founded | 2017 |
| Employees | 14 |
| 52-week range | $0.27 – $2.38 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-02 | — | -0.2448 | — | $0.00 |
| 2026-05-07 | -0.28 | -0.2907 | $0.00 | $0.00 |
| 2026-03-27 | -0.17 | -0.3519 | $0.00 | $0.00 |
Related companies
